MedPath
FDA Approval

LUMOXITI

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Innate Pharma, Inc.
DUNS: 117202909
Effective Date
September 3, 2020
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Polysorbate 80(6.5 mg in 1 mL)

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

IV STABILIZER

Product Details

NDC Product Code
73380-4715
Application Number
BLA761104
Marketing Category
BLA (C73585)
Route of Administration
INTRAVENOUS
Effective Date
August 31, 2020
Code: 6OZP39ZG8HClass: ACTIBQuantity: 6.5 mg in 1 mL
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACTQuantity: 0.7 mg in 1 mL
TRISODIUM CITRATE DIHYDRATEInactive
Code: B22547B95KClass: IACTQuantity: 6.4 mg in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACTQuantity: 1 mg in 1 mL

LUMOXITI

Product Details

NDC Product Code
73380-4700
Application Number
BLA761104
Marketing Category
BLA (C73585)
Route of Administration
INTRAVENOUS
Effective Date
August 31, 2020
Code: 2NDX4B6N8FClass: ACTIBQuantity: 1 mg in 1 mL
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEInactive
Code: 593YOG76RNClass: IACTQuantity: 3.4 mg in 1 mL
GLYCINEInactive
Code: TE7660XO1CClass: IACTQuantity: 80 mg in 1 mL
POLYSORBATE 80Inactive
Code: 6OZP39ZG8HClass: IACTQuantity: 0.2 mg in 1 mL
SUCROSEInactive
Code: C151H8M554Class: IACTQuantity: 40 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath